Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Project Grant - PA: Human Development, Child and Youth Health

University of Guelph

$100,000.00

Control of Synapse Organizer LGI1 by Cannabinoid Signalling: Focus on Prefrontal Cortex Development and Schizophrenia

EF 2024-25

Résumé
Brain disorders pose a heavy burden on society in part due to the escalating costs associated with care and treatment, and the fact that nearly all currently available drugs to treat these conditions have limited efficacy and/or significant side effects. A deeper understanding of the pathways controlling brain development and neuroplasticity will help identify opportunities to discover better pharmacological therapies. Synapses are made of hundreds of proteins that work together to create brain activity. Small changes in the level of a core synaptic protein can have devastating consequences on mood, cognition, and behavior. Although we know a great deal about how these structures grow and create communication between neuronal cells, many individual protein players still need to be studied to reveal their specific role and importance. This research project focuses on LGI1 (Leucine-rich, Glioma Inactivated 1)-a protein that accumulates outside neurons and helps connect the pre- and postsynaptic regions. Specifically, we will study how LGI1 is expressed during development and change when specific receptors are stimulated by delta-9-tetrahydrocannabinol (THC), which is the main molecule in cannabis affecting the mind and mental processes. We will also explore if a link exists between LGI1 and the mental illness schizophrenia using patient-derived stem cell models and post-mortem brain samples. Overall, our efforts will provide new knowledge to understand better the importance of LGI1 to neuron development and its potential contribution to schizophrenia, and the effect of THC on LGI1 activity and function.
Programme
Project Grant - PA: Human Development, Child and Youth Health
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
514937
Name
Lalonde Jasmin
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Pharmacology & Toxicology
Projecttitle
Control of Synapse Organizer LGI1 by Cannabinoid Signalling: Focus on Prefrontal Cortex Development and Schizophrenia
Programtype2
Operating Grants
Orgnameinp2
University of Guelph
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant - PA: Human Development, Child and Youth Health
Keyworddelim
Activity-Dependent Regulation; Brain Development; Cannabinoid Signalling; Cellular And Molecular Neurosciences; Cerebral Cortex; Induced Pluripotent Stem Cells; Schizophrenia; Signal Transduction; Synapse Formation; Thc
Abstract
Brain disorders pose a heavy burden on society in part due to the escalating costs associated with care and treatment, and the fact that nearly all currently available drugs to treat these conditions have limited efficacy and/or significant side effects. A deeper understanding of the pathways controlling brain development and neuroplasticity will help identify opportunities to discover better pharmacological therapies. Synapses are made of hundreds of proteins that work together to create brain activity. Small changes in the level of a core synaptic protein can have devastating consequences on mood, cognition, and behavior. Although we know a great deal about how these structures grow and create communication between neuronal cells, many individual protein players still need to be studied to reveal their specific role and importance. This research project focuses on LGI1 (Leucine-rich, Glioma Inactivated 1)-a protein that accumulates outside neurons and helps connect the pre- and postsynaptic regions. Specifically, we will study how LGI1 is expressed during development and change when specific receptors are stimulated by delta-9-tetrahydrocannabinol (THC), which is the main molecule in cannabis affecting the mind and mental processes. We will also explore if a link exists between LGI1 and the mental illness schizophrenia using patient-derived stem cell models and post-mortem brain samples. Overall, our efforts will provide new knowledge to understand better the importance of LGI1 to neuron development and its potential contribution to schizophrenia, and the effect of THC on LGI1 activity and function.
Competitiondate
202409
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lalonde, Jasmin
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~